Yoosakul, E., Seeduang, C., Chuasuwan, B., Manamuti, C., Pitisuttithum, P., Karachot, B. and Techatanawat, I. 2017. Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovel® 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasti. Journal of Health Research. 30, 3 (Feb. 2017), 199–205.